pioglitazone has been researched along with Urethral Obstruction in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Urethral Obstruction: Partial or complete blockage in any part of the URETHRA that can lead to difficulty or inability to empty the URINARY BLADDER. It is characterized by an enlarged, often damaged, bladder with frequent urges to void.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Wang, J | 1 |
| Zhou, QD | 1 |
| Zhang, CH | 1 |
| Li, Q | 1 |
| Huang, S | 1 |
| Zhan, J | 1 |
| Wang, K | 1 |
| Liu, YY | 1 |
| Xu, G | 1 |
1 other study available for pioglitazone and Urethral Obstruction
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor-γ agonist pioglitazone fails to attenuate renal fibrosis caused by unilateral ureteral obstruction in mice.
Topics: Animals; Chemokine CCL2; Fibrosis; Kidney; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Pioglita | 2016 |